NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Deepak Nitrite Ltd Benefits from Indian Government's Anti-Dumping Duty Proposal

The Indian government's consideration of imposing an anti-dumping duty on imports of Diamino Stilbene Disulphonic Acid (Dasda) from China has provided some relief to Deepak Nitrite Ltd's investors. The Directorate General of Trade Remedies (DGTR) has found merit in the company's complaint, validating its stance.

The DGTR has proposed a reference-price-based duty, where importers would be required to pay the difference between the arrival price and a reference price of $3,453 per tonne. This move is expected to provide a favorable outcome for Deepak Nitrite Ltd, which has been impacted by the import of cheap Dasda from China.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Investor Takeaway

Investors in Deepak Nitrite Ltd may benefit from the anti-dumping duty on Dasda imports from China.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.